Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Push Health vs VitaFusions IV

Push Health
Graded #419

Lower grade

vs+5.899999999999999
VitaFusions IV
Graded #279

Higher grade

The verdict

VitaFusions IV takes it — 62.1/100 to 56.2/100.

VitaFusions IV grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VitaFusions IV (vitafusionsiv.com) offers semaglutide and medical weight loss services in Dallas, TX.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitaFusions IV +23
35
58
Dose & formulationVitaFusions IV +7
65
72
Clinical oversightVitaFusions IV +3
71
74
Labs & monitoringVitaFusions IV +1
52
53
FulfillmentPush Health +5
67
62
Contract termsPush Health +18
55
37
Push Health · left barVitaFusions IV · right bar

The numbers

MetricPush HealthVitaFusions IV
WeighScore56.2/10062.1/100
GradeCC
Scorecard rank#419#279
Semaglutide$950/mo (brand-name)$149/mo (all doses, plus a separate fee, compounded)
TirzepatideNot disclosed$189/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Push Health

Graded #419 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified
VitaFusions IV

Graded #279 · C

Strengths

  • Semaglutide confirmed from page metadata
  • Published flat package pricing: semaglutide from $149, tirzepatide $189 for a 7-week supply, no insurance/memberships/contracts

Where it loses points

  • Advertised prices are 7-week package prices, not monthly; homepage banner ('$199 for 7 weeks') conflicts with the program page ('Starting $149')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard